Red Meat vs Plant-Based Meat: 10-Week Trial Results

A 10-week randomized dietary intervention conducted in New Zealand found no significant differences in cardiometabolic biomarkers between healthy young adults consuming pasture-raised red meat and those consuming commercial plant-based meat alternatives. Published online ahead of print on October 1, 2026, in The American Journal of Clinical Nutrition, the trial observed that plasma concentrations of the long-chain omega-3 fatty acid docosapentaenoic acid (DPA) declined in the plant-based alternative group between baseline and week 5 and then recovered, compared with the red meat group. The findings provide new experimental data comparing whole animal proteins with formulated substitutes within healthy dietary patterns.

Key takeaways:

• A 10-week New Zealand randomized trial published in AJCN on October 1, 2026, found no differences in cardiometabolic biomarkers between adults eating pasture-raised beef and lamb versus plant-based meat alternatives.
• The abstract reports plasma omega-3 DPA concentrations declined in the plant-based alternative group between baseline and week 5, followed by a recovery between weeks 5 and 10, compared with the red meat group.
• Among 259 measured lipid species, only PE-O 39:6 remained statistically significant after multiple testing correction, declining in the vegetarian group while holding steady in the flexitarian group.
• The 78-person trial involved healthy young adults aged 18 to 35 clustered in household pairs, eating either moderate amounts of red meat (3.3 servings a week by week 10) or soy- and pea-protein meat alternatives.

What happened

On October 1, 2026, researchers published results from a 10-week randomized trial comparing the physiological effects of pasture-raised red meat against plant-based meat alternatives (PBMAs). The paper, authored by L. Morton, D. Cameron-Smith, N. Gillies, K. Fraser, and A. Braakhuis, appeared online ahead of print in The American Journal of Clinical Nutrition (PubMed abstract, doi:10.1016/j.ajcnut.2026.101564).

The investigators represent the University of Auckland, the Riddet Institute at Massey University, and the Bioeconomy Sciences Institute in New Zealand. The trial was registered on ClinicalTrials.gov as NCT04869163 as the "PREDITION" trial, with the University of Auckland serving as lead sponsor alongside collaborators AgResearch and the University of Otago.

We could not access the full text of the paper, so the findings below come from the published abstract. The abstract reports that 78 healthy participants completed the free-living dietary intervention. The authors evaluated polyunsaturated fatty acid status and broad cardiometabolic indicators across both dietary arms.

What changed

To compare these protein sources, the study assigned healthy adults to follow one of two structured dietary patterns for 10 weeks. One arm consumed a flexitarian diet incorporating moderate amounts of pasture-raised red meat, reaching 3.3 servings per week at week 10. The alternate arm followed an ovo-lacto vegetarian diet incorporating commercial plant-based meat alternatives.

Cardiometabolic and lipid biomarkers were evaluated at baseline, week 5, and week 10 using linear mixed-effects models that accounted for household clustering and applied Benjamini-Hochberg false discovery rate corrections for multiple comparisons. The abstract reports: "No intervention × time effects were observed for cardiometabolic biomarkers."

The abstract reports that omega-3 DPA "exhibited a significant intervention × time interaction, reflecting a decline in the vegetarian group between baseline and week 5 compared with the flexitarian group (estimate = -6.47 μmol/L, 95% CI: -10.39 to -2.56 μmol/L; p = 0.001), followed by recovery between week 5 and week 10 (estimate = -4.15 μmol/L, 95% CI: -8.07 to -0.24 μmol/L; p = 0.038). Following Benjamini-Hochberg correction, DPA remained significant (FDR-adjusted p = 0.030)."

Furthermore, the authors tracked 259 distinct lipid species to assess broader lipidomic shifts. The abstract notes that "Among 259 lipid species, PE-O 39:6 was the only species remaining significant after correction for multiple testing ... remaining stable in the flexitarian group but declining in the vegetarian group." The authors concluded: "Inclusion of moderate amounts of pasture-raised red meat did not adversely affect cardiometabolic biomarkers and was associated with maintenance of plasma DPA concentrations compared to a vegetarian dietary pattern incorporating PBMAs."

Who is affected

The population studied in this intervention was specific and tightly defined. According to the published trial protocol in JMIR Research Protocols (2021) and a 2024 companion paper in Current Developments in Nutrition, the trial recruited 80 healthy omnivorous young adults aged 18 to 35, organized as 40 cohabitating household pairs. Randomization occurred at the household cluster level so that partners consumed the same intervention foods.

Volunteers were generally free from chronic health conditions. Eligibility criteria on ClinicalTrials.gov specified the exclusion of individuals with obesity (defined as a body mass index of 30 kg/m² or greater), pre-existing hyperlipidemia, or regular prescription medication use. Consequently, the findings reflect outcomes in a young, metabolically healthy cohort.

The foods provided were also distinct. The flexitarian group received fresh New Zealand pasture-raised red meat, consisting of beef mince, beef steak, lamb rack, and lamb leg. The PBMA group received locally available commercial brands formulated from soy protein, pea protein, and vegetable oils, supplied as mince and patties. Both groups received weekly meal kits supporting an otherwise standard ovo-lacto vegetarian diet.

What it means for shoppers

For shoppers choosing between meat and packaged alternatives, this small, short trial in healthy young adults found no difference in the cardiometabolic markers it measured. However, it also illustrates that meat and formulated alternatives have very different ingredient and nutritional profiles.

Plant-based mince and patties are formulated, multi-ingredient products rather than whole foods. As published in the trial's original design protocol, the vegetarian analogues used in this study contained substantially more sodium and saturated fat per 100 grams than the lean red meat cuts: the vegetarian mince contained 368 mg of sodium and 8.2 g of saturated fat, compared to 47 mg of sodium and 2.5 g of saturated fat in lean beef. These figures come from the protocol's product table; they are not results of the trial.

Shoppers monitoring specific nutrient targets must look carefully at the Nutrition Facts panel and ingredient statements on packaged alternatives. The abstract does not name the brands used or list their ingredients, so read the ingredient statement on the specific product you buy.

Consumers should also consider overall processing. Packaged meat alternatives are often counted as ultra-processed foods; for what trials of ultra-processed food do and do not show, see Ultra-Processed Food Trials: Weight Gain Clear, Cause Less So. Checking labels allows buyers to verify whether a plant-based substitute provides whole legume ingredients or isolated proteins with added sodium.

The background

This is one of several recent diet trials comparing meat-based and plant-based eating; another measured a different outcome, covered in Vegan vs Meat-Rich Diet: Mold Toxins in Urine After 8 Weeks.

Funding transparency is essential when interpreting nutritional intervention data. While the AJCN paper's specific manuscript funding statement was not accessible to us, the trial's published protocol outlines its support: "This study is funded by the Meat Industry Association Innovation Limited (a subsidiary of the New Zealand Meat Industry Association), Beef + Lamb New Zealand Incorporated, and the New Zealand Ministry of Business, Innovation and Employment. The funders are not involved in the collection, analysis, and interpretation of the data, writing of the reports, or in the decision to submit manuscripts for publication."

The protocol also discloses that author A. Braakhuis "has received funding from the Meat Industry Association to investigate the nutrient composition of NZ beef" and from commercial meat companies. Furthermore, the 2024 companion paper in Current Developments in Nutrition notes that the project "was partially funded by industry trade associations that represent companies supplying almost all of New Zealand meat exports."

An additional methodological detail appears in the trial registry. ClinicalTrials.gov lists the primary outcome as polyunsaturated fatty acid (PUFA) concentrations measured "in erythrocyte membranes." However, the published AJCN abstract reports fatty acid status in blood plasma.

What to watch next

While this study provides randomized evidence over 10 weeks, significant scientific questions remain unresolved. Most notably, a finding of "no differences in cardiometabolic biomarkers" over 78 healthy participants does not demonstrate that either dietary pattern prevents or causes long-term cardiovascular disease.

Several specific details were not disclosed in the available abstract. The abstract did not specify the exact commercial PBMA brands or their full ingredient lists, the specific individual cardiometabolic biomarkers tested, the separate numerical results for EPA or DHA, or the exact breakdown of randomized versus completed participants per study arm.

Furthermore, the results cannot be generalized beyond the specific parameters of the trial. The intervention used pasture-raised New Zealand beef and lamb; the results do not necessarily apply to grain-fed beef, highly processed meats like bacon or cured sausages, or older populations living with pre-existing metabolic conditions.

Future research will need to clarify whether changes in specific lipid species like PE-O 39:6 or transient drops in plasma DPA translate into clinically relevant health outcomes. In the meantime, shoppers evaluating meat alternatives can inspect nutritional values and additive panels independently.